Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. WISCONSIN EMPLOYERS ON WHITE BAGGING… Recently, we introduced you to the
Chief Corporate Affairs Officer, Humana Inc. Dr. William K. Fleming is Chief Corporate Affairs Officer for Humana. William is a member of the Management Team, which sets the firm’s strategic direction, and reports to President and Chief Executive Officer Bruce
Court Ruling Finds that ERISA Preempts State PBM Law COURT REJECTS BID TO PREEMPT ERISA…In a unanimous decision, the U.S. Court of Appeals for the Tenth Circuit in PCMA v. Mulready court sustained PCMA’s challenge to four provisions in
During this time of public health emergency, PBMs know the importance of pharmacies remaining focused on providing patient care. PBMs believe there needs to be a balance between helping pharmacies manage the influx of COVID-19 related patient needs and
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s Executive Order to resurrect the rebate rule. “The Administration’s decision last year to withdraw a proposed regulation on prescription drug
(Washington, D.C.) — As employers confront a challenging economic environment and are examining options to both reduce costs and improve health care quality for workers, a national survey of benefit managers and human resources directors from North Star Opinion Research
Research Advocacy Documents External Resources
This week, the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee considers legislation that would lower choice in the market by creating a one-size-fits all pharmacy benefit contracting model for health plans and employers. As Congress considers mandating contracting
In case you missed it, Jason Altmire, former Democratic three-term U.S. Representative from Pennsylvania and current adjunct professor at Texas Tech University, explains why so-called “delinking” proposals would be catastrophic for patients and families’ pocketbooks in an op-ed in RealClearHealth.
©2024 PCMA. All Rights Reserved.
